Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Neutra's gross profit for the twelve months ending Oct 31, 2023 was $8.03K, down 86.9% year over year. For fiscal 2023 it was $35.31K, up 13.3% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | $35.31K | +13.3% |
| FY2022 | Jan 31, 2022 | $31.16K | – |
| FY2021 | Jan 31, 2021 | -$33.26K | -620.0% |
| FY2020 | Jan 31, 2020 | $6.40K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $589 | -94.5% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $1.68K | -89.8% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $2.80K | -45.3% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $2.95K | -89.7% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $10.68K | +547.4% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $16.55K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $5.12K | +296.6% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $28.74K | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $1.65K | +127.1% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$524 | -118.6% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $1.29K | -35.8% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$38.81K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $726 | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $2.82K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $2.01K | – |
See a number that looks wrong?